This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Glucagonlike Peptide-1 Receptor Agonists: The Good, the Bad, and the Ugly-Benefits for Glucose Control and Weight Loss with Side Effects of Delaying Gastric Emptying.
Journal of nuclear medicine technology, 52(1), 3-7
Citation
Parkman, Henry P; Rim, Daniel S; Anolik, Jonathan R; Dadparvar, Simin; Maurer, Alan H. (2024). Glucagonlike Peptide-1 Receptor Agonists: The Good, the Bad, and the Ugly-Benefits for Glucose Control and Weight Loss with Side Effects of Delaying Gastric Emptying.. Journal of nuclear medicine technology, 52(1), 3-7. https://doi.org/10.2967/jnmt.123.266800